Arabinofuranosyluracil (Ara-U) CAS 3083-77-0 Intende ≥99.0% Factory High Quality Featured Image

Arabinofuranosyluracil (Ara-U) CAS 3083-77-0 Intende ≥99.0% Factory Quality

Description:

Nomen chemicum: Arabinofuranosyluracil (Ara-U)

CAS: 3083-77-0

Aspectus: Albus vel Fere Albus Crystallinus Pulvis

Dic: ≥99.0% (ex sicco basis)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple Arabinonucleosides Intermedia cum High puritate
Vidarabine;Ara-A;CAS: 5536-17-4
Arabinofuranosyluracil;Ara-U ;CAS: 3083-77-0
Cytarabine;Ara-C;CAS: 147-94-4

Chemical Properties:

Nomen chemicum	Arabinofuranosyluracil
Synonyma	Ara-U;1-β-D-Arabinofuranosyluracil;Uracil 1-β-D-Arabinofuranoside
CAS Number	3083-77-0
CATTUS Number	RF-PI217
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C9H12N2O6
M. Pondus	244.20
Liquescens punctum	220.0~222.0℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba aut fere alba Crystallina pulveris
Damnum in Siccatio	≤0.50%
Residere in Ignition	≤0.10%
Assay	≥98.0% (ex exaruit basis)
Metalla gravia (Pb)	≤10ppm
Ferrum (Fe)	≤10ppm
Arsenicum (As2O3)	≤1ppm
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.

commoda:

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum Arabinofuranosyluracil (CAS: 3083-77-0) magna qualitate, late in synthesi organica, synthesi pharmaceuticae intermediorum et API synthesis.Antiviral Agent.Arabinofuranosyluracil (CAS: 3083-77-0) adhibetur ad curationem syndromi respiratorii acuta gravi (SARS).Arabinofuranosyluracil media pharmaceutica adhibetur ad synthesin Cytarabinae (CAS: 147-94-4).Cytarabine est medicamentum antivirale quod contra tumores etiam adhibetur, praecipue leukemia.